A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
NCT05470348
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Solid Tumor
Interventions
DRUG:
BL-B01D1
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators
[object Object]
[object Object]